|
Age (year)
|
57.29 ± 9.39
|
58.16 ± 9.58
|
0.170
|
|
Male [n(%)]
|
328 (76.3)
|
363 (78.2)
|
0.486
|
|
Weight (kg)
|
72.04 ± 12.08
|
72.64 ± 13.05
|
0.487
|
|
Hypertension [n(%)]
|
245 (57.2)
|
276 (59.5)
|
0.448
|
|
Diabetes [n(%)]
|
98 (22.8)
|
94 (20.3)
|
0.357
|
|
Stroke [n(%)]
|
14 (3.3)
|
11 (2.4)
|
0.423
|
|
Prior myocardial infarction [n(%)]
|
50 (11.6)
|
74 (15.9)
|
0.060
|
|
Current smoker [n(%)]
|
224 (52.1)
|
246 (53.0)
|
0.782
|
|
ACS [n(%)]
| | | |
|
Unstable angina
|
216 (50.2)
|
296 (68.3)
|
0.658
|
|
Non-ST-elevation ACS
|
52 (12.1)
|
49 (10.6)
|
0.477
|
|
ST-elevation MI
|
162(37.7)
|
119 (25.6)
|
<0.001
|
|
Target vessel position [n(%)]
| | | |
|
Left Main
|
53 (12.3)
|
66 (14.2)
|
0.397
|
|
Left Anterior Descending
|
278 (64.7)
|
295 (63.6)
|
0.771
|
|
Left Circumflex
|
36 (8.4)
|
39 (8.4)
|
0.978
|
|
Right Coronary Artery
|
46 (10.9)
|
45 (9.7)
|
0.629
|
|
PCI
| | | |
|
Average stent diameter (mm)
|
3.03 ± 0.40
|
3.06 ± 0.40
|
0.181
|
|
Average length of stents (mm)
|
27.17 ± 5.96
|
27.58 ± 5.89
|
0.293
|
|
Average number of stents
|
1.85 ± 0.96
|
1.89 ± 1.02
|
0.627
|
|
Transradial artery invasive [n(%)]
|
378 (87.9)
|
408 (87.9)
|
0.991
|
|
Tirofiban (d)
|
1.84 ± 0.66
|
1.90 ± 0.62
|
0.495
|
|
Fondaparinux/enoxaparin (d)
|
4.75 ± 1.81
|
4.57 ± 1.75
|
0.168
|
|
Laboratory examination
| | | |
|
APTT (s)
|
33.39 ± 5.86
|
32.97 ± 5.57
|
0.271
|
|
Prothrombin time (s)
|
12.97 ± 1.38
|
12.90 ± 1.07
|
0.381
|
|
HDL-C (mmol/L)
|
1.19 ± 0.44
|
1.18 ± 0.58
|
0.639
|
|
Creatinine (mmol/L)
|
87.50 ± 18.71
|
91.02 ± 15.02
|
0.116
|
|
PLT (×109/L)
|
212.29 ± 56.09
|
212.50 ± 51.13
|
0.954
|
